BACKGROUND: Suboptimal adherence to antiretroviral therapy (ART) is a strong predictor of virologic failure (VF) among people with HIV. Various methods such as patient self-report, pill counts and pharmacy refills have been utilized to monitor adherence. However, there are limited data on the accuracy of combining methods to better predict VF in routine clinical settings. We examined various methods to assess adherence including pill count, medication possession ratio (MPR), and self-reported adherence in order to determine which was most highly associated with VF after > 6 months on ART. METHODS: We conducted a secondary analysis of data from a case-control study. At enrollment, pharmacy refill data were collected retrospectively from the medical chart, pill counts were completed to derive a pill count adherence ratio (PCAR) and a self-report questionnaire was administered to all participants. Parametric smooth splines and receiver operator characteristic (ROC) analyses were carried out to assess the accuracy of the adherence methods. RESULTS: 458 patients were enrolled from October 2010 to June 2012. Of these, 158 (34.50%) experienced VF (cases) and 300 (65.50%) were controls. The median (IQR) PCAR was 1.10 (0.99-1.14) for cases and 1.13 (1.08-1.18) for controls (p < 0.0001). The median MPR was 1.00 (0.97-1.07) for cases and 1.03 (0.96-1.07) for controls (p = 0.83). Combination of PCAR and self-reported questions was highly associated with VF. CONCLUSION: In this setting, a combination of pill count adherence and self-report adherence questions had the highest diagnostic accuracy for VF. Further validation of this simple, low-cost combination is warranted in large prospective studies.
BACKGROUND: Suboptimal adherence to antiretroviral therapy (ART) is a strong predictor of virologic failure (VF) among people with HIV. Various methods such as patient self-report, pill counts and pharmacy refills have been utilized to monitor adherence. However, there are limited data on the accuracy of combining methods to better predict VF in routine clinical settings. We examined various methods to assess adherence including pill count, medication possession ratio (MPR), and self-reported adherence in order to determine which was most highly associated with VF after > 6 months on ART. METHODS: We conducted a secondary analysis of data from a case-control study. At enrollment, pharmacy refill data were collected retrospectively from the medical chart, pill counts were completed to derive a pill count adherence ratio (PCAR) and a self-report questionnaire was administered to all participants. Parametric smooth splines and receiver operator characteristic (ROC) analyses were carried out to assess the accuracy of the adherence methods. RESULTS: 458 patients were enrolled from October 2010 to June 2012. Of these, 158 (34.50%) experienced VF (cases) and 300 (65.50%) were controls. The median (IQR) PCAR was 1.10 (0.99-1.14) for cases and 1.13 (1.08-1.18) for controls (p < 0.0001). The median MPR was 1.00 (0.97-1.07) for cases and 1.03 (0.96-1.07) for controls (p = 0.83). Combination of PCAR and self-reported questions was highly associated with VF. CONCLUSION: In this setting, a combination of pill count adherence and self-report adherence questions had the highest diagnostic accuracy for VF. Further validation of this simple, low-cost combination is warranted in large prospective studies.
Authors: Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson Journal: BMJ Date: 2006-06-21
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Gert Uves van Zyl; Thijs E van Mens; Helen McIlleron; Michele Zeier; Jean B Nachega; Eric Decloedt; Carolina Malavazzi; Peter Smith; Yong Huang; Lize van der Merwe; Monica Gandhi; Gary Maartens Journal: J Acquir Immune Defic Syndr Date: 2011-04 Impact factor: 3.731
Authors: Kevin C Henderson; Jason Hindman; Steven C Johnson; Robert J Valuck; Jennifer J Kiser Journal: AIDS Patient Care STDS Date: 2011-02-16 Impact factor: 5.078
Authors: Vincent C Marconi; Baohua Wu; Jane Hampton; Claudia E Ordóñez; Brent A Johnson; Dinesh Singh; Sally John; Michelle Gordon; Anna Hare; Richard Murphy; Jean Nachega; Daniel R Kuritzkes; Carlos del Rio; Henry Sunpath Journal: AIDS Patient Care STDS Date: 2013-12 Impact factor: 5.078
Authors: Tamsin Phillips; Kirsty Brittain; Claude A Mellins; Allison Zerbe; Robert H Remien; Elaine J Abrams; Landon Myer; Ira B Wilson Journal: AIDS Behav Date: 2017-02
Authors: Habib O Ramadhani; Charles Muiruri; Venance P Maro; Balthazar Nyombi; Michael Omondi; Julian B Mushi; Eileen S Lirhunde; John A Bartlett Journal: AIDS Behav Date: 2018-05
Authors: Suzanne M McCluskey; Toby Pepperrell; Andrew Hill; Willem D F Venter; Ravindra K Gupta; Mark J Siedner Journal: AIDS Date: 2021-12-15 Impact factor: 4.177
Authors: Sally John; Rachel Kearns; Brent A Johnson; Claudia E Ordóñez; Baohua Wu; Anna Hare; Peng Wu; Patrick Sullivan; Henry Sunpath; Vincent C Marconi Journal: New Voices Psychol Date: 2016
Authors: Jonathan Colasanti; Darius McDaniel; Brent Johnson; Carlos Del Rio; Henry Sunpath; Vincent C Marconi Journal: AIDS Res Hum Retroviruses Date: 2015-12-09 Impact factor: 2.205
Authors: Robin Wood; Gary Maartens; Catherine Orrell; Karen Cohen; Rory Leisegang; David R Bangsberg Journal: AIDS Res Ther Date: 2017-04-04 Impact factor: 2.250
Authors: Sharon Tsui; Caitlin E Kennedy; Lawrence H Moulton; Larry W Chang; Jason E Farley; Kwasi Torpey; Eric van Praag; Olivier Koole; Nathan Ford; Fred Wabwire-Mangen; Julie A Denison Journal: Trop Med Int Health Date: 2021-08-08 Impact factor: 2.622
Authors: Anne M Neilan; Audrey C Bangs; Michael Hudgens; Kunjal Patel; Allison L Agwu; Ingrid V Bassett; Aditya H Gaur; Emily P Hyle; Catherine M Crespi; Keith J Horvath; Caitlin M Dugdale; Kimberly A Powers; H Jonathon Rendina; Milton C Weinstein; Rochelle P Walensky; Kenneth A Freedberg; Andrea L Ciaranello Journal: AIDS Behav Date: 2021-02-06
Authors: Aaloke Mody; Ingrid Eshun-Wilson; Kombatende Sikombe; Sheree R Schwartz; Laura K Beres; Sandra Simbeza; Njekwa Mukamba; Paul Somwe; Carolyn Bolton-Moore; Nancy Padian; Charles B Holmes; Izukanji Sikazwe; Elvin H Geng Journal: PLoS Med Date: 2019-10-29 Impact factor: 11.069